How Good is China's ICSI Single Sperm Injection Technology: A Comprehensive Analysis from Technical Principles to Clinical Application

AI Summary

Direct Answer: The Essence and Clinical Positioning of ICSI Technology

ICSI (Intracytoplasmic Sperm Injection) is the core technology of second-generation IVF. Unlike conventional IVF where sperm and eggs naturally combine in a culture dish, ICSI involves an embryologist using micromanipulation to directly inject a single sperm into the oocyte cytoplasm to complete fertilization. This technology has nearly 30 years of clinical history in China and is a mature, stable assisted reproductive method.

The core problem ICSI addresses is fertilization failure, especially fertilization difficulties caused by male factors. From clinical data, the fertilization rate of ICSI is generally higher than that of conventional IVF (with normal sperm quality, conventional IVF fertilization rate is about 60%–70%, ICSI about 70%–85%), but ICSI does not directly improve egg quality or embryo developmental potential, nor does it increase the probability of obtaining a transferable embryo per egg. It merely bypasses the natural barriers of sperm penetration through the zona pellucida and oolemma, providing a "direct channel" for sperm.

In China, ICSI technology has been incorporated into the standardized management of assisted reproductive technology, and all reproductive centers performing IVF have ICSI operational capability. However, ICSI is a "use-on-demand" technology and is not necessary for all IVF cycles. Whether to use ICSI depends on the cause of infertility, semen analysis results, previous treatment history, and laboratory quality control requirements.

Operational Procedure of ICSI in an Actual IVF Cycle

ICSI itself is not a complete IVF cycle but the method of fertilization operation. An IVF cycle including ICSI is divided into the following stages:

1. Pre-treatment Examination and Evaluation: Both partners complete fertility assessments, including semen analysis (at least 2 times), female ovarian function evaluation (AMH, FSH, antral follicle count), infectious disease screening, chromosome karyotype analysis, etc.
2. Ovarian Stimulation and Follicle Monitoring: The female receives an ovarian stimulation protocol, with follicle development monitored via ultrasound and hormones, and trigger injection administered at the appropriate time.
3. Egg Retrieval Surgery: Transvaginal ultrasound-guided follicle puncture to retrieve eggs, obtaining cumulus-oocyte complexes.
4. Oocyte Evaluation and Preparation: The embryologist assesses oocyte maturity under a microscope (MII oocytes are used for ICSI), removes granulosa cells, and prepares the microinjection dish.
5. Sperm Processing and Selection: Semen is processed via density gradient centrifugation or swim-up to obtain motile sperm. For obstructive azoospermia, sperm is obtained through testicular or epididymal aspiration.
6. ICSI Microinjection: Using a micromanipulator, the embryologist picks up a single sperm with an injection needle and injects it into the oocyte cytoplasm from the polar body position. The entire process is performed on a workstation outside the incubator, maintaining constant temperature, humidity, and sterility.
7. Fertilization Check and Embryo Culture: Fertilization is checked 16–18 hours after injection (presence of pronuclei), and embryos are cultured to the cleavage or blastocyst stage.
8. Embryo Transfer and Luteal Support: High-quality embryos are selected for transfer, and remaining embryos are cryopreserved.

The entire ICSI operation takes about 3–5 minutes per oocyte and requires a high level of technical proficiency from the embryologist. Reproductive centers in China have strict training and assessment systems for embryologists, who must complete a specified number of ICSI operations annually to maintain qualification.

Key Examination Indicators Affecting ICSI Outcomes

The following indicators directly affect ICSI fertilization rates, embryo quality, and final pregnancy outcomes:

It is worth noting that sperm DNA fragmentation index is an easily overlooked indicator. Even with normal sperm concentration and motility, a high DFI can affect blastocyst formation and implantation rates after ICSI. Some domestic reproductive centers have included DFI as a routine pre-ICSI examination item.

Clinical Decision-Making Logic of Reproductive Physicians

As reproductive physicians, the following evidence-based approach is followed when deciding whether to use ICSI:

• Clear Indications: Severe oligozoospermia (concentration < 5×10⁶/mL), asthenozoospermia (PR < 10%), teratozoospermia (normal morphology < 1%), obstructive azoospermia (sperm obtained via TESA/PESA), previous IVF cycle fertilization failure (fertilization rate < 30%), use of frozen-thawed sperm, PGT cycles (to avoid polyspermy interfering with diagnosis).
• Relative Indications: Unexplained infertility (ICSI can improve fertilization rate but not live birth rate), elevated sperm DNA fragmentation index, very low oocyte number (to maximize the use of each oocyte).
• Not Recommended for Routine Use: Women with non-male factor infertility and no history of previous fertilization failure. Multiple studies show that in non-male factor cycles, there is no significant difference in live birth rates between conventional IVF and ICSI, but ICSI is more expensive and involves more operational steps.

Differences in ICSI Outcomes Across Different Age Groups

Age is the primary non-male factor affecting ICSI outcomes. The main differences across age groups are as follows:

• Female ≤ 35 years: Good ovarian reserve, sufficient oocyte yield, ICSI fertilization rate usually reaches 75%–85%, cumulative live birth rate is higher. In this age group, the difference between ICSI and conventional IVF is mainly in fertilization rate, not final pregnancy rate.
• Female 36–40 years: Ovarian reserve begins to decline, oocyte yield decreases, oocyte aneuploidy rate increases. The advantage of ICSI is ensuring fertilization (avoiding fertilization failure due to oocyte aging), but the embryo chromosomal abnormality rate increases with age; combining with PGT-A is recommended.
• Female > 40 years: Oocyte yield significantly decreases, oocyte quality declines, ICSI fertilization rate can still be maintained at 65%–75%, but blastocyst formation and implantation rates decrease. At this stage, ICSI is mainly used to "rescue every available oocyte," but patients should be fully informed of the relatively low expected live birth rate.

The impact of male age on ICSI is relatively small, but sperm DNA fragmentation index may increase in men aged ≥ 45, affecting blastocyst development. Some centers recommend supplementing sperm DNA fragmentation index testing for older fathers undergoing ICSI.

Typical Clinical Scenarios and ICSI Application Analysis

Scenario 1: Severe Oligoasthenozoospermia

Male patient, 32 years old, semen analysis shows concentration 1.2×10⁶/mL, PR 8%, normal morphology 2%. Female partner 30 years old, AMH 3.6 ng/mL. After ICSI, 12 oocytes were retrieved, 10 were MII, 8 fertilized, 4 blastocysts formed, 1 was transferred resulting in a singleton pregnancy. In this scenario, ICSI is the only feasible fertilization method and cannot be replaced by conventional IVF.

Scenario 2: Complete Fertilization Failure in Previous IVF Cycle

Female patient, 33 years old, male partner's semen parameters are normal. In the first IVF cycle, 10 MII oocytes all failed to fertilize. The second cycle was changed to ICSI, with a fertilization rate of 80%, and a successful delivery after transfer. This scenario represents "unexplained fertilization failure," and ICSI is an effective rescue solution.

Scenario 3: Obstructive Azoospermia (OA)

Male patient, 36 years old, semen analysis shows no sperm, testicular aspiration yields sufficient motile sperm. Female partner 34 years old, all parameters normal. In the ICSI cycle, frozen-thawed testicular sperm was used for injection, fertilization rate was 72%, 3 high-quality embryos were formed, 1 was transferred resulting in a live birth. In this scenario, ICSI is an irreplaceable technical pathway.

Key Details Easily Overlooked in ICSI Technology

• Sperm Immobilization and Activation: Before ICSI injection, sperm must be immobilized using PVP or mechanical methods to activate the sperm plasma membrane and promote oocyte activation. Insufficient immobilization may lead to decreased fertilization rates.
• Polar Body Position and Injection Direction: The injection needle should enter from the 6 o'clock or 12 o'clock position to avoid damaging the spindle. Using polarized light microscopy can visualize the spindle position, reducing the risk of oocyte damage.
• Oocyte Zona Pellucida Thickness: An excessively thick or hard zona pellucida may hinder needle penetration, requiring adjustment of injection angle and force.
• Oocyte Survival Rate After Injection: Under normal circumstances, the oocyte survival rate after ICSI should be > 95%. If the survival rate is low, injection technique, culture medium pH, or temperature fluctuations should be investigated.
• Genetic Counseling Omission: Patients with severe oligozoospermia need to be screened for Y chromosome microdeletions and chromosomal structural abnormalities to avoid passing genetic defects to offspring. Some centers do not routinely provide genetic counseling before ICSI, which is a management gap.
• Laboratory Temperature Chain: Oocytes and sperm are extremely sensitive to temperature during in vitro manipulation; the workstation temperature should be maintained at 37°C ± 0.5°C. Temperature fluctuations exceeding 1°C may affect spindle stability and fertilization rates.

These details are incorporated into standard operating procedures (SOP) in professional reproductive centers, but when choosing a center, patients can pay attention to the experience of the embryology team and the laboratory quality control system.

Frequently Asked Questions about ICSI

Which is better, ICSI or conventional IVF?

There is no absolute "better," only "more suitable." For couples with normal sperm quality, there is no significant difference in live birth rates between conventional IVF and ICSI, but conventional IVF is less expensive and simpler. For severe male factor or previous fertilization failure, ICSI is the only option.

How much more does ICSI cost compared to conventional IVF?

In China, ICSI typically adds 5,000–12,000 RMB to the cost of conventional IVF, depending on the region, center level, and whether testicular sperm is used. Some centers include ICSI fees in the total cycle cost.

What is the success rate of ICSI?

The fertilization rate for ICSI is usually 70%–85%, but the final pregnancy rate depends on multiple factors such as embryo quality, endometrial receptivity, and age. There is no single "success rate"; it requires individualized assessment.

What are the sperm requirements for ICSI?

Theoretically, as long as one viable sperm can be obtained from semen or testicular tissue, ICSI can be performed. However, sperm DNA fragmentation index, morphology, and motility affect embryo developmental potential.

Does ICSI increase the risk of birth defects in babies?

Current research shows that the overall birth defect rate for ICSI is comparable to conventional IVF (about 2%–4%), but ICSI may slightly increase the risk of sex chromosome abnormalities and a few rare genetic syndromes. This risk is mainly related to paternal factors rather than the technique itself. Genetic counseling is recommended before an ICSI cycle.

How long does ICSI take?

The ICSI procedure itself takes only 3–5 minutes per oocyte, but the entire IVF cycle from examination to transfer takes about 2–3 months. ICSI does not extend the cycle duration.